Bibliografia UJ CM

1/2
David M. Reid, Jean-Pierre Devogelaer, Kenneth Saag, Christian Roux, Chak-Sing Lau, Jean-Yves Reginster, Philemon Papanastasiou, Alberto Ferreira, Florian Hartl, Taiwo Fashola, Peter Mesenbrink, Philip N. Sambrook, HORIZON investigators.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
2009 : Vol. 373, nr 9671, s. 1253-1263, il., bibliogr. 33 poz.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 30.758
2/2
Kenneth W. Lyles, Cathleen S. Colón-Emeric, Jay S. Magaziner, Jonathan D. Adachi, Carl F. Pieper, Carlos Mautalen, Lars Hyldstrup, Chris Recknor, Lars Nordsletten, Kathy A. Moore, Catherine Lavecchia, Jie Zhang, Peter Mesenbrink, Patricia K. Hodgson, Ken Abrams, John J. Orloff, Zebulun Horowitz, Erik Fink Eriksen, Steven Boonen, HORIZON Reccurent Fracture Trial.
Zoledronic acid and clinical fractures and mortality after hip fracture.
New England Journal of Medicine
2007 : Vol. 357, nr 18, s. 1799-1809, il., bibliogr. 30 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 52.589
Wyświetl ponownie stosując format: